Illinois General Assembly - Full Text of HB1544
Illinois General Assembly

Previous General Assemblies

Full Text of HB1544  95th General Assembly

HB1544 95TH GENERAL ASSEMBLY


 


 
95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB1544

 

Introduced 2/22/2007, by Rep. Joe Dunn

 

SYNOPSIS AS INTRODUCED:
 
New Act

    Creates the Clinical Laboratory Science Practice Act. Provides for the regulation of clinical laboratory practitioners, medical technologists, and medical laboratory technicians through licensure by the Department of Financial and Professional Regulation. Preempts home rule. Effective immediately.


LRB095 05319 RAS 25399 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY
FISCAL NOTE ACT MAY APPLY
HOME RULE NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB1544 LRB095 05319 RAS 25399 b

1     AN ACT concerning regulation.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 1. Short title. This Act may be cited as the
5 Clinical Laboratory Science Practice Act.
 
6     Section 5. Declaration of policy; purpose. It is hereby
7 declared to be a policy of this State that the practice of
8 clinical laboratory science by health care professionals
9 affects the public health, safety, and welfare and is subject
10 to control and regulation in the public interest. It is further
11 declared that clinical laboratories and clinical laboratory
12 practitioners provide essential services to practitioners of
13 the healing arts by furnishing vital information that may be
14 used in the diagnosis, prevention, and treatment of disease or
15 impairment and the assessment of the health of humans. The
16 purpose of this Act is to assure better protection of public
17 health by requiring minimum qualifications for clinical
18 laboratory practitioners and by ensuring that clinical
19 laboratory tests are performed with the highest degree of
20 professional competency by those engaged in providing such
21 services in this State.
 
22     Section 15. Definitions. The following words and terms

 

 

HB1544 - 2 - LRB095 05319 RAS 25399 b

1 when used in the Act shall have the following meaning unless
2 otherwise indicated within the context:
3     "Accredited clinical laboratory education program" means a
4 program planned to provide a predetermined amount of
5 instruction and experience in clinical laboratory science,
6 medical technology, or cytology that has been accredited by one
7 of the accrediting agencies approved by the U.S. Department of
8 Health and Human Services.
9     "Board" means the Clinical Laboratory Science Board
10 appointed by the Secretary of Financial and Professional
11 Regulation.
12     "Categorical technologist" means an individual eligible
13 under this Act who is qualified to perform clinical laboratory
14 testing in one or more categories of laboratory testing, such
15 as microbiology, clinical chemistry, immunology, hematology,
16 immunohematology or other areas specified by the Board. The
17 categorical technologist is responsible for the establishment
18 and implementation of protocols, quality assessment, method
19 development and selection, equipment selection and
20 maintenance, and all activities related to the pre-analytical,
21 analytical, and post-analytical phases of testing. The
22 categorical technologist may also direct, supervise, consult,
23 educate, and perform research functions in their specialty
24 area. "Categorical technologist" includes a categorical
25 scientist.
26     "CLIA '88" means the Clinical Laboratory Improvement

 

 

HB1544 - 3 - LRB095 05319 RAS 25399 b

1 Amendments of 1988.
2     "Clinical laboratory" or "laboratory" means a site or
3 location in which clinical laboratory tests or examinations are
4 performed.
5     "Clinical laboratory practitioner" means an individual who
6 has the authority to perform clinical laboratory tests.
7     "Clinical laboratory scientist" means an individual
8 eligible under this Act that performs any clinical laboratory
9 test including those that require the exercise of independent
10 judgment. In addition, this individual is responsible for the
11 establishment and implementation of protocols, quality
12 assessment, method development and selection, equipment
13 selection and maintenance, and all activities related to the
14 pre-analytical, analytical and post-analytical phases of
15 testing. The clinical laboratory scientist may also direct,
16 supervise, consult, educate, and perform research functions.
17     "Clinical laboratory technician" means an individual
18 eligible under this Act who is qualified to perform clinical
19 laboratory tests pursuant to established and approved
20 protocols that require limited exercise of independent
21 judgment and which are performed with oversight from a clinical
22 laboratory scientist, medical technologist, technical
23 consultant, supervisor, or laboratory director as defined by
24 the Clinical Laboratory Improvement Amendments of 1988 (CLIA
25 '88) (P.L. 100-578).
26     "Clinical laboratory test" or "laboratory test" means a

 

 

HB1544 - 4 - LRB095 05319 RAS 25399 b

1 microbiological, serological, molecular, chemical, biological,
2 hematological, immunological, immunohematological,
3 cytological, biophysical, or any other test or procedure
4 performed on material derived from or existing in a human body
5 that provides information for the diagnosis, prevention, or
6 monitoring of a disease or impairment or assessment of a
7 clinical condition. Clinical laboratory testing encompasses
8 the pre-analytical, analytical, and post-analytical phases of
9 testing.
10     "Cytotechnologist" means an individual eligible under this
11 Act who is qualified to process and interpret cellular material
12 derived from the human body delineating data regarding human
13 cytopathological disease. The cytotechnologist performs
14 testing under the supervision of a technical supervisor
15 pursuant to the CLIA '88. The cytotechnologist reviews and
16 interprets gynecological cytology preparations and screens
17 non-gynecological cytology preparations where final review and
18 interpretation is the responsibility of a qualified physician.
19     "Department" means the Department of Financial and
20 Professional Regulation.
21     "Histotechnician" means an individual who is qualified to
22 process cellular and tissue components through methods of
23 selected gross dissection and description, fixation,
24 dehydration, embedding, microtomy, frozen sectioning,
25 staining, and other related procedures and techniques employed
26 in the preparation of smears, slides, and tissues. This

 

 

HB1544 - 5 - LRB095 05319 RAS 25399 b

1 specialty also encompasses methods for antigen detection and
2 other molecular hybridization testing methods where the
3 purpose is analysis or quantification of cellular and tissue
4 components for interpretation by a qualified physician. The
5 histotechnician performs testing under the direct supervision
6 of a histotechnologist, technical consultant, supervisor, or
7 laboratory director as defined by CLIA '88.
8     "Histotechnologist" means an individual who is qualified
9 to process cellular and tissue components through methods of
10 selected gross dissection and description, fixation,
11 dehydration, embedding, microtomy, frozen sectioning,
12 staining, and other related procedures and techniques employed
13 in the preparation of smears, slides and tissues. This
14 specialty also encompasses methods for antigen detection and
15 other molecular hybridization testing methods where the
16 purpose is analysis or quantification of cellular and tissue
17 components for interpretation by a qualified physician. The
18 histotechnologist performs testing under the supervision of a
19 technical consultant, supervisor, or laboratory director as
20 defined by CLIA '88.
21     "Medical technologist" means an individual eligible under
22 this Act that performs any clinical laboratory test including
23 those that require the exercise of independent judgment. In
24 addition, this individual is responsible for the establishment
25 and implementation of protocols, quality assessment, method
26 development and selection, equipment selection and

 

 

HB1544 - 6 - LRB095 05319 RAS 25399 b

1 maintenance, and all activities related to the pre-analytical,
2 analytical, or post-analytical phases of testing. The medical
3 technologist may also direct, supervise, consult, educate, and
4 perform research functions.
5     "Medical laboratory technician" means an individual
6 eligible under this Act who is qualified to perform clinical
7 laboratory tests pursuant to established and approved
8 protocols that require limited exercise of independent
9 judgment and which are performed with oversight from a clinical
10 laboratory scientist, medical technologist, technical
11 consultant, supervisor, or laboratory director as defined by
12 the Clinical Laboratory Improvement Amendments of 1988.
13     "Pathologist's assistant" means an individual who is
14 qualified to perform surgical pathology specimen examinations
15 and post-mortem examinations. This specialty also encompasses
16 related functions which are necessary to insure the successful
17 completion or processing of the above. The pathologist's
18 assistant performs testing under the supervision of a qualified
19 pathologist. The functions of the pathologist's assistant
20 shall be to assist a pathologist in arriving at a final
21 diagnosis. Rendering the final diagnosis, however, is the
22 responsibility of a pathologist.
23     "Point of care testing" means clinical testing that is so
24 critical to patient care that it must be performed immediately
25 at or near the patient. Tests meeting this definition provide
26 clinically relevant information that direct therapy, are

 

 

HB1544 - 7 - LRB095 05319 RAS 25399 b

1 limited to procedures that produce accurate and precise data in
2 a short period of time, meet the current standards of quality
3 in laboratory science, and comply with all standards of
4 accrediting agencies. The term does not include a clinical
5 laboratory test performed in a physician's office laboratory.
6     "Secretary" means the Secretary of Financial and
7 Professional Regulation.
8     "Waived test" means a simple laboratory examination or
9 procedure, as defined by the CLIA '88 and approved by the
10 Board.
 
11     Section 20. Exemptions. This Act does not apply to any of
12 the following:
13         (1) A person licensed in this State under any other Act
14     who engages in the practice for which he or she is
15     licensed, providing the Act specifically authorizes him or
16     her to perform laboratory testing.
17         (2) Clinical laboratory practitioners employed by the
18     United States government or any bureau, division, or agency
19     thereof while in the discharge of the employee's official
20     duties.
21         (3) Clinical laboratory practitioners engaged in
22     teaching or research, provided that the results of any
23     examination performed are not used in health maintenance,
24     diagnosis, or treatment of disease.
25         (4) Students or trainees enrolled in a clinical

 

 

HB1544 - 8 - LRB095 05319 RAS 25399 b

1     laboratory education program, provided that these
2     activities constitute a part of a planned course in the
3     program, that the persons are designated by title such as
4     intern, trainee, or student, and the persons work directly
5     under (i) an individual licensed by this State to practice
6     clinical laboratory science, (ii) a person exempt from
7     licensure under this Act by item (3) of this Section, or
8     (iii) a licensed physician.
9         (5) A person solely performing waived tests under the
10     Clinical Laboratory Improvement Amendments of 1988 (P.L.
11     100-578).
12         (6) Personnel performing point of care testing
13     provided that, within the point of care testing laboratory,
14     a licensed Clinical laboratory scientist, medical
15     technologist, categorical technologist, clinical
16     laboratory technician, medical laboratory technician, or
17     licensed physician is responsible for all of the following:
18             (A) Designing and providing or supervising the
19         training programs for the point of care testing
20         personnel.
21             (B) Supervising and monitoring the quality
22         assurance and quality control activities of the
23         testing site.
24             (C) Assisting in the selection of technology.
25             (D) Reviewing the results of proficiency testing
26         and recommending corrective action, if necessary.

 

 

HB1544 - 9 - LRB095 05319 RAS 25399 b

1             (E) Monitoring the continued competency of the
2         testing personnel. Failure to comply with the above
3         requirements subjects the point of care testing
4         personnel to the loss of the exemption.
5         (7) Histotechnicians and histotechnologists who
6     perform clinical laboratory testing under the supervision
7     of a technical consultant, supervisor, or laboratory
8     director as defined by the CLIA '88.
9         (8) Pathologist's assistants who perform clinical
10     laboratory testing under the supervision of a qualified
11     pathologist.
 
12     Section 25. License required.
13     (a) Beginning January 1, 2008, no person shall perform or
14 consult regarding clinical laboratory tests or hold himself or
15 herself out as a clinical laboratory practitioner in the State
16 unless he or she is licensed under this Act.
17     (b) All persons performing or consulting regarding
18 clinical laboratory tests on the effective date of this Act who
19 are certified by or eligible for certification by an agency
20 acceptable to the Department and who have applied to the
21 Department on or before January 1, 2008 and have complied with
22 all necessary requirements for application may continue to
23 perform clinical laboratory tests until (1) the expiration of
24 12 months after filing the application, (2) the denial of the
25 application by the Department, or (3) the withdrawal of the

 

 

HB1544 - 10 - LRB095 05319 RAS 25399 b

1 application, whichever occurs first.
2     (c) Before January 1, 2010, a person not meeting the
3 education, training, and experience qualifications for a
4 license under this Act may be granted licensure if they have 3
5 years of acceptable experience at the professional level for
6 which licensure is sought immediately prior to the effective
7 date of this Act and submit to the Board the job description of
8 the position that the applicant has most recently performed,
9 attested to by his or her employer.
10     (D) Beginning January 1, 2010, no initial license shall be
11 issued until an applicant meets all of the requirements under
12 this Act and successfully completes a national certification
13 examination authorized by the Department.
 
14     Section 30. Administration.
15     (a) The Department shall adopt rules consistent with the
16 provisions of this Act for the administration and enforcement
17 thereof and may prescribe the forms that shall be issued in
18 connection with this Act. The rules shall include standards and
19 criteria for licensure and professional conduct and
20 discipline. The Department shall consult with the Board in
21 adopting rules. Notice of proposed rulemaking shall be
22 transmitted to the Board and the Department shall review the
23 Board's response and any recommendations the Board makes. The
24 Department shall notify the Board in writing with an
25 explanation of its deviations from the Board's recommendations

 

 

HB1544 - 11 - LRB095 05319 RAS 25399 b

1 and response.
2     (b) The Department may solicit the advice and expert
3 knowledge of the Board on any matter relating to the
4 administration and enforcement of this Act.
5     (c) The Department shall issue to the Board a quarterly
6 report of the status of all complaints related to the
7 profession received by the Department.
 
8     Section 35. Clinical Laboratory Science Board.
9     (a) There is hereby created a Clinical Laboratory Science
10 Board within the Department of Financial and Professional
11 Regulation which shall consist of 8 persons who have been
12 residents of this State for at least 2 years prior to their
13 appointment and who are actively engaged in their areas of
14 practice. The Secretary may make appointments to the Board from
15 lists submitted by organizations of clinical laboratory
16 science practitioners and organizations of physician
17 pathologists.
18     (b) The Board shall be composed of the following members:
19 (i) one physician certified by the American Board of Pathology
20 or the American Board of Osteopathic Pathology; (ii) 6 clinical
21 laboratory practitioners who, except for initial appointments,
22 hold active and valid licenses as clinical laboratory
23 practitioners in this State, at least one of whom is a
24 non-physician laboratory director, as defined by the CLIA '88,
25 2 of whom are clinical laboratory scientists or medical

 

 

HB1544 - 12 - LRB095 05319 RAS 25399 b

1 technologists, one of whom is a clinical laboratory technician
2 or medical laboratory technician, and one of whom is a
3 cytotechnologist; and (iii) one public member who is not
4 associated with or financially interested in the practice of
5 clinical laboratory science.
6     (c) Board members shall serve for a term of 3 years and
7 until their successors are appointed and qualified, except that
8 the initial appointments, which shall be made within 60 days
9 after the effective date of this Act, shall be as follows:
10         (1) A pathologist, a non-physician laboratory
11     director, as defined by the CLIA '88, and 2 clinical
12     laboratory practitioners shall be appointed to serve for 3
13     years.
14         (2) A public representative shall be appointed to serve
15     for 2 years.
16         (3) The remaining members shall be appointed to serve
17     for one year.
18     (d) Whenever a vacancy shall occur on the Board by reason
19 other than the expiration of a term of office, the Secretary
20 shall appoint a successor of like qualifications for the
21 remainder of the unexpired term. No person shall be appointed
22 to serve more than 2 successive 3-year terms.
23     (e) The Secretary shall have the authority to remove any
24 member of the Board from office for neglect of any duty
25 required by law or for incompetency or unprofessional or
26 dishonorable conduct.

 

 

HB1544 - 13 - LRB095 05319 RAS 25399 b

1     (f) The Secretary shall consider the recommendations of the
2 Board on questions involving standards of professional
3 conduct, discipline, and qualifications of applicants or
4 licensees under this Act.
 
5     Section 40. Standards for licensure.
6     (a) The Department shall issue a clinical laboratory
7 scientist or medical technologist license to an individual who
8 meets the qualifications promulgated by the Department,
9 including successful performance on a national certification
10 examination at the clinical laboratory scientist or medical
11 technologist level authorized by the Department and at least
12 one of the following:
13         (1) Baccalaureate degree in clinical laboratory
14     science or medical technology or the equivalent from an
15     accredited college or university and successful completion
16     of an accredited clinical laboratory science or medical
17     technology education program.
18         (2) Baccalaureate degree from an accredited college or
19     university and completion of 36 semester hours in the
20     biological, chemical, or medical laboratory sciences in
21     addition to or part of the baccalaureate degree and
22     successful completion of an accredited clinical laboratory
23     science or medical technology education program or
24     successful completion of a 50-week or more military medical
25     laboratory training program.

 

 

HB1544 - 14 - LRB095 05319 RAS 25399 b

1         (3) Baccalaureate degree from an accredited college or
2     university and completion of 36 semester hours in the
3     biological, chemical, or medical laboratory sciences in
4     addition to or part of the baccalaureate degree, certified
5     as a clinical laboratory technician or medical laboratory
6     technician, and completion of the equivalent of 2 years of
7     full-time clinical laboratory work experience within the
8     last 4 years. This experience must have included a minimum
9     of 4 months in each of the 4 major clinical laboratory
10     disciplines (chemistry or urinalysis, hematology,
11     immunohematology, and microbiology).
12         (4) Baccalaureate degree from an accredited college or
13     university and completion of 36 semester hours in the
14     biological, chemical, or medical laboratory sciences in
15     addition to or part of the baccalaureate degree and
16     completion of the equivalent of 4 years of full-time
17     clinical laboratory work experience within the last 8
18     years. This experience must have included a minimum of 4
19     months in each of the 4 major clinical laboratory
20     disciplines (chemistry or urinalysis, hematology,
21     immunohematology, and microbiology).
22     (b) The Department shall issue a categorical technologist
23 license to an individual who meets such qualifications as
24 promulgated by the Department, including successful
25 performance on a categorical examination offered by a national
26 certification organization authorized by the Department and at

 

 

HB1544 - 15 - LRB095 05319 RAS 25399 b

1 least one of the following:
2         (1) For the categories of microbiology and chemistry,
3     (i) a baccalaureate degree from an accredited college or
4     university, (ii) successful completion of 30 semester
5     hours in the biological, chemical, or medical laboratory
6     sciences, and (iii) one year of full-time experience within
7     the last 10 years in the category for which licensure is
8     sought or successful completion of a structured training
9     program that is under the auspices of an accredited medical
10     technology or clinical laboratory science education
11     program in the category for which licensure is sought.
12         (2) For the categories of hematology, immunology, and
13     immunohematology, (i) a baccalaureate degree from an
14     accredited college or university, (ii) successful
15     completion of 30 semester hours in the biological, chemical
16     or medical laboratory sciences, and (iii) 2 years of
17     full-time experience within the last 10 years in the
18     category for which licensure is sought or successful
19     completion of a structured training program that is under
20     the auspices of an accredited medical technology or
21     clinical laboratory science education program in the
22     category for which licensure is sought.
23         (3) A masters or doctorate in a chemical, biological,
24     or medical laboratory science from an accredited college or
25     university and 6 months of full time acceptable clinical
26     laboratory experience or clinical laboratory training

 

 

HB1544 - 16 - LRB095 05319 RAS 25399 b

1     within the last 10 years in the category for which
2     licensure is sought.
3     The Department may establish other categorical
4 technologist licenses as necessary, provided that the licenses
5 require a baccalaureate or graduate degree in an appropriate
6 field, clinical training or work experience, and national
7 certification.
8     (c) The Department shall issue a clinical laboratory
9 technician or medical laboratory technician license to an
10 individual who meets such qualifications as promulgated by the
11 Department, which shall include successful performance on a
12 national certification examination at the clinical laboratory
13 technician or medical laboratory technician level authorized
14 by the Department and at least one of the following:
15         (1) Associate's degree or 60 semester hours from an
16     accredited post-secondary academic institution and
17     successful completion of an accredited clinical laboratory
18     technician or medical laboratory technician education
19     program.
20         (2) Associate's degree or 60 semester hours from an
21     accredited post-secondary academic institution with 24
22     semester hours of college course work in the biological,
23     chemical, or medical laboratory sciences, including 6
24     semester hours of chemistry and 6 semester hours of biology
25     and successful completion of a 50-week or more military
26     medical laboratory training program.

 

 

HB1544 - 17 - LRB095 05319 RAS 25399 b

1         (3) Associate's degree or 60 semester hours from an
2     accredited post-secondary academic institution with 24
3     semester hours of college course work in the biological,
4     chemical, or medical laboratory sciences, including 6
5     semester hours of chemistry and 6 semester hours of biology
6     and successful completion of an approved laboratory or
7     clinical assistant education program, and completion of
8     the equivalent of one year of full-time clinical laboratory
9     work experience within the last 2 years. This experience
10     must have included a minimum of 3 months in each of the 4
11     major clinical laboratory disciplines (chemistry or
12     urinalysis, hematology, immunohematology, and
13     microbiology). Laboratory work experience must be under
14     the supervision of a certified clinical laboratory
15     scientist or medical technologist, certified clinical
16     laboratory technician or medical laboratory technician.
17         (4) Associate's degree or 60 semester hours from an
18     accredited post-secondary academic institution with 24
19     semester hours of college course work in the biological,
20     chemical, or medical laboratory sciences, including 6
21     semester hours of chemistry and 6 semester hours of biology
22     and completion of the equivalent of 2 years of full-time
23     clinical laboratory work experience within the last 4
24     years. This experience must have included a minimum of 3
25     months in each of the 4 major clinical laboratory
26     disciplines (chemistry or urinalysis, hematology,

 

 

HB1544 - 18 - LRB095 05319 RAS 25399 b

1     immunohematology, and microbiology). Completion of one
2     year of the laboratory work experience must be under the
3     supervision of a certified clinical laboratory scientist
4     or medical technologist, certified clinical laboratory
5     technician or medical laboratory technician.
6     (d) The Department shall issue a cytotechnologist license
7 to an individual who meets such qualifications as promulgated
8 by the Department, which shall include successful performance
9 on a national certification examination at the
10 cytotechnologist level authorized by the Department and a
11 baccalaureate degree from an accredited college or university
12 with 20 semester hours of biological science and 8 semester
13 hours of chemical science, and successful completion of an
14 accredited cytology laboratory education program.
 
15     Section 45. Temporary license.
16     (a) Licensure applicants that qualify by education,
17 experience, or training but have not taken or passed an
18 approved nationally recognized certification examination may
19 be granted a temporary license that will allow that individual
20 to engage in the practice of clinical laboratory science at the
21 appropriate level. The temporary license will be valid for 6
22 months and can be renewed twice upon failure to pass an
23 approved nationally recognized certification examination.
24     (b) Internationally trained licensure applicants must have
25 their transcripts evaluated by a transcript evaluation agency

 

 

HB1544 - 19 - LRB095 05319 RAS 25399 b

1 acceptable to the Department and submitted directly to the
2 national certifying agency. The evaluation must indicate that
3 the applicant's education is equivalent to that which is
4 required for licensure of U.S. graduates in the level of
5 licensure being sought. Upon submission of proof to the
6 Department of acceptance to sit for the certification
7 examination the individual may apply for a temporary license in
8 the corresponding category.
 
9     Section 50. Waiver of requirements. The Department of
10 Financial and Professional Regulation shall adopt rules
11 providing procedures for waiver of the requirements under
12 Section 40 for all applicants who hold a valid license or
13 equivalent issued by another state if the requirements under
14 which that license or equivalent was issued are equivalent to
15 or exceed the standards required by this Act.
 
16     Section 55. Licensure application procedures.
17     (a) Licensure applicants shall submit their application
18 for licensure to the Department upon the forms prescribed and
19 furnished by the Department and shall pay the designated
20 application fee.
21     (b) Upon receipt of an application and payment of a fee,
22 the Department shall issue a license for a clinical laboratory
23 scientist or medical technologist, categorical technologist,
24 clinical laboratory technician or medical laboratory

 

 

HB1544 - 20 - LRB095 05319 RAS 25399 b

1 technician, or cytotechnologist, to any person who meets the
2 qualifications specified in this Act and the rules adopted
3 pursuant to this Act.
 
4     Section 60. Licensure renewal.
5     (a) A license issued under this Act shall expire 2 years
6 after receipt.
7     (b) Every person licensed under this Act shall be issued a
8 renewal license upon (i) submission of an application for
9 renewal on a form prescribed by the Department and payment of
10 an appropriate fee determined by the Department and (ii) proof
11 of completion, in the period since the license was first issued
12 or last renewed, of at least 24 hours of continuing education
13 courses, clinics, lectures, training programs, seminars, or
14 other programs related to clinical laboratory practice that are
15 approved or accepted by the Board or proof of recertification
16 by a national accrediting organization that mandates an annual
17 minimum of 12 hours of continuing education.
18     (c) The Department may require other such evidence of
19 competency as it shall deem reasonably appropriate as a
20 prerequisite to the renewal of any license provided for in this
21 Act, so long as the requirements are uniform as to application,
22 are reasonably related to the measurement of qualification,
23 performance, or competence, and are desirable and necessary for
24 the protection of the public health.
 

 

 

HB1544 - 21 - LRB095 05319 RAS 25399 b

1     Section 65. Disciplinary grounds.
2     (a) The Department may refuse to issue or renew or revoke a
3 license, may suspend, place on probation, censure, or reprimand
4 a licensee, or may take such other disciplinary action as the
5 Department may deem appropriate, including the imposition of a
6 civil penalty not to exceed $5,000 for conduct that may result
7 from but not necessarily be limited to any of the following:
8         (1) A material misstatement in furnishing information
9     to the Department.
10         (2) A violation or negligent or intentional disregard
11     of this Act or the rules adopted pursuant to this Act.
12         (3) A conviction of any crime under the laws of the
13     United States or any state or territory thereof which is a
14     felony or a misdemeanor, an essential element of which is
15     dishonesty or of any crime which is directly related to the
16     practice of the profession.
17         (4) Making any misrepresentation for the purpose of
18     obtaining registration or violating any provision of this
19     Act.
20         (5) Professional incompetence.
21         (6) Malpractice.
22         (7) Failing to provide information in response to a
23     written request made by the Department within 60 days after
24     receipt of the request.
25         (8) Discipline by another state, territory, or country
26     if at least one of the grounds for the discipline is the

 

 

HB1544 - 22 - LRB095 05319 RAS 25399 b

1     same or substantially equivalent to those set forth in this
2     Act.
3         (9) Directly or indirectly giving to or receiving from
4     any person, firm, corporation, partnership, or association
5     any fee, commission, rebate, or other form of compensation
6     for any professional services not actually rendered.
7         (10) A finding by the Department that the licensee,
8     after having his license placed on probationary status, has
9     violated the terms of probation.
10         (11) Wilfully making or filing false records or reports
11     in his or her practice, including but not limited to, false
12     records filed with State agencies or departments.
13         (12) Violation of any standard of professional conduct
14     adopted by the Department.
15         (13) Engaging in dishonorable, unethical, or
16     unprofessional conduct of a character likely to deceive,
17     defraud, or harm the public.
18         (14) Providing professional services while mentally
19     incompetent or under the influence of alcohol or narcotic
20     or controlled dangerous substance that is in excess of
21     therapeutic amounts or without valid medical indication.
22         (15) Directly or indirectly contracting to perform
23     clinical laboratory tests in a manner that offers or
24     implies an offer of rebate, fee-splitting inducements or
25     arrangements, or other remuneration.
26         (16) Aiding or assisting another person in violating

 

 

HB1544 - 23 - LRB095 05319 RAS 25399 b

1     any provision of this Act or any rule adopted pursuant to
2     this Act.
3     (b) The determination by a circuit court that a licensee is
4 subject to involuntary admission or judicial admission as
5 provided in the Mental Health and Developmental Disabilities
6 Code operates as an automatic suspension. Such suspension will
7 terminate only upon a finding by a court that the patient is no
8 longer subject to involuntary admission or judicial admission
9 and the issuance of an order so finding and discharging the
10 patient, and upon the recommendation of the Board to the
11 Secretary that the registrant be allowed to resume practice.
12     (c) The Department may refuse to issue or may suspend the
13 registration of any person who fails to file a return, to pay
14 the tax, penalty, or interest shown in a filed return, or any
15 final assessment of tax, penalty, or interest, as required by
16 any tax Act administered by the Illinois Department of Revenue,
17 until such time as the requirements of such tax Act are
18 satisfied.
 
19     Section 70. Injunction; cease and desist order.
20     (a) If any person violates a provision of the Act, the
21 Secretary may, in the name of the People of the State of
22 Illinois, through the Attorney General of the State of
23 Illinois, petition for an order enjoining such violation or for
24 an order enforcing compliance with the Act. Upon the filing of
25 a verified petition in such court, the court may issue a

 

 

HB1544 - 24 - LRB095 05319 RAS 25399 b

1 temporary restraining order, without notice or bond, and may
2 preliminarily and permanently enjoin such violation, and if it
3 is established that such person has violated or is violating
4 this injunction, the Court may punish the offender for contempt
5 of court. Proceeding under this Section shall be in addition
6 to, and not in lieu of, all other remedies and penalties
7 provided by the Act.
8     (b) If any person shall practice as a clinical laboratory
9 practitioner or hold himself out as such without having a valid
10 license required under this Act, then any licensee, any
11 interested party, or any person injured thereby may, in
12 addition to the Secretary, petition for relief as provided in
13 subsection (a) of the Section.
14     (c) Whenever in the opinion of the Department any person
15 violates any provision of the Act, the Department may issue a
16 rule to show cause why an order to cease and desist should not
17 be entered against him. The rule shall clearly set forth the
18 grounds relied upon by the Department and shall provide a
19 period of 7 days from the date of the rule to file an answer to
20 the satisfaction of the Department. Failure to answer to the
21 satisfaction of the Department shall cause an order to cease
22 and desist to be issued.
 
23     Section 75. Investigations. The Department may
24 investigate the actions of any applicant or of any person or
25 persons holding or claiming to hold a license to engage in the

 

 

HB1544 - 25 - LRB095 05319 RAS 25399 b

1 practice of clinical laboratory science. Before refusing to
2 issue or renew a license, the Department shall notify in
3 writing the applicant or holder of the nature of the charges
4 and that a hearing will be held on the date designated. Such
5 notice shall be sent at least 10 calendar days prior to the
6 date set for the hearing. Such written notice may be served by
7 personal delivery or certified or registered mail to the
8 respondent at the address of his last notification to the
9 Department. At the time and place fixed in the notice, the
10 Board shall proceed to hear the charges and the parties or
11 their counsel shall be accorded ample opportunity to present
12 such statements, testimony, evidence and argument as may be
13 pertinent to the charges or to the defense thereto. The Board
14 may continue such hearing.
 
15     Section 80. Record of proceedings. The Department, at its
16 expense, shall preserve a record of all proceedings at the
17 formal hearing of any case involving the refusal to issue or
18 renew a license. The notice of hearing, complaint and all other
19 documents in the nature of pleadings and written motions filed
20 in the proceedings, the transcript of testimony, the report of
21 the Board and orders of the Department shall be the record of
22 such proceedings.
 
23     Section 85. Compel witnesses. Any circuit court may, upon
24 application of the Department or its designee, or of the

 

 

HB1544 - 26 - LRB095 05319 RAS 25399 b

1 applicant or licensee against whom proceedings under Section 70
2 of the Act are pending, enter an order requiring the attendance
3 of witnesses and their testimony, and the production of
4 documents, papers, files, books, and records in connection with
5 any hearing or investigation. The court may compel obedience to
6 its order by proceedings for contempt.
 
7     Section 90. Findings of fact, conclusions of law, and
8 recommendations. At the conclusion of the hearing, the Board
9 shall present to the Secretary a written report of its findings
10 and recommendations. The report shall contain a finding whether
11 or not the accused person violated this Act or failed to comply
12 with the conditions required in this Act. The Board shall
13 specify the nature of the violation or failure to comply, and
14 shall make its recommendations to the Secretary.
15     The report of findings of fact, conclusions of law, and
16 recommendations of the Board shall be the basis for the
17 Department's order for refusal or for the granting of a license
18 or for other disciplinary action. If the Secretary disagrees in
19 any regard with the report of the Board, the Secretary may
20 issue an order in contravention thereof. The Secretary shall
21 provide a written report to the Board on any deviation and
22 shall specify with particularity the reasons for such action in
23 the final order. The finding is not admissible in evidence
24 against the person in a criminal prosecution brought for the
25 violation of this Act, but the hearing and finding are not a

 

 

HB1544 - 27 - LRB095 05319 RAS 25399 b

1 bar to a criminal prosecution brought for the violation of this
2 Act.
 
3     Section 95. Motion for rehearing. In any case involving
4 the refusal to issue or renew a license or to discipline a
5 licensee, a copy of the Board's report shall be served upon the
6 respondent by the Department, either personally or as provided
7 in this Act for the service of the notice of hearing. Within 20
8 calendar days after such service, the respondent may present to
9 the Department a motion in writing for a rehearing, which
10 motion shall specify the particular grounds therefor. If no
11 motion for rehearing is filed, then upon the expiration of the
12 time specified for filing such a motion, or if a motion for
13 rehearing is denied, then upon such denial the Secretary may
14 enter an order in accordance with recommendations of the Board,
15 except as provided for in Section 85. If the respondent shall
16 order from the reporting service, and pay for a transcript of
17 the record within the time for filing a motion for rehearing,
18 the 20 calendar day period within which such a motion may be
19 filed shall commence upon the delivery of the transcript to the
20 respondent.
 
21     Section 100. Rehearing. Whenever the Secretary is not
22 satisfied that substantial justice has been done in the
23 revocation, suspension or refusal to issue or renew a license,
24 the Secretary may order a rehearing by the same or other

 

 

HB1544 - 28 - LRB095 05319 RAS 25399 b

1 examiners.
 
2     Section 105. Hearing officer. The Secretary shall have the
3 authority to appoint any attorney duly licensed to practice law
4 in the State of Illinois to serve as the hearing officer in any
5 action or refusal to issue or renew a license or discipline a
6 licensee. The Secretary shall notify the Board of any such
7 appointment. The hearing officer shall have full authority to
8 conduct the hearing. The hearing officer shall report his
9 finding of fact, conclusions of law, and recommendations to the
10 Board and the Secretary. The Board shall have 60 days from
11 receipt of the report to review the report of the hearing
12 officer and present its own findings of fact, conclusions of
13 law and recommendations to the Secretary. If the Board fails to
14 present its report within the 60 day period, the Secretary
15 shall issue an order based on the report of the hearing
16 officer. If the Secretary disagrees in any regard with the
17 report of the Board or hearing officer, he may issue an order
18 in contravention thereof. The Secretary shall provide a written
19 explanation to the Board of any such deviation and shall
20 specify with particularity the reasons for such action in the
21 final order. At least 2 licensed clinical laboratory
22 practitioner members of the Board shall be present at all
23 formal hearings on the merits of complaints brought under the
24 provisions of this Act.
 

 

 

HB1544 - 29 - LRB095 05319 RAS 25399 b

1     Section 110. Prima facie proof. An order or a certified
2 copy thereof, over the seal of the Department and purporting to
3 be signed by the Secretary, shall be prima facie proof that:
4         (1) the signature is the genuine signature of the
5     Secretary;
6         (2) the Secretary is duly appointed and qualified; and
7         (3) the Board and its members are qualified to act.
 
8     Section 115. Restoration. At any time after the suspension
9 or revocation of any license, the Department may restore the
10 license to the accused person, upon the written recommendation
11 of the Board, unless after an investigation and a hearing, the
12 Board determines that restoration is not in the public
13 interest.
 
14     Section 120. Surrender of license. Upon the revocation or
15 suspension of any license, the licensee shall forthwith
16 surrender the license to the Department, and if the licensee
17 fails to do so, the Department shall have the right to seize
18 the license.
 
19     Section 125. Temporary suspension. The Secretary may
20 temporarily suspend the license of a clinical laboratory
21 practitioner without a hearing, simultaneously with the
22 institution of proceedings for a hearing as provided in Section
23 70 of this Act, if the Secretary finds that evidence in his or

 

 

HB1544 - 30 - LRB095 05319 RAS 25399 b

1 her possession indicates that a clinical laboratory
2 practitioner's continuation in practice would constitute an
3 imminent danger to the public. In the event that the Secretary
4 suspends temporarily the license of a clinical laboratory
5 practitioner without a hearing, a hearing by the Board must be
6 held within 30 calendar days after such suspension has
7 occurred.
 
8     Section 130. Judicial review. All final administrative
9 decisions of the Department are subject to judicial review
10 pursuant to the provisions of the Administrative Review Law and
11 all rules adopted pursuant thereto. The term "administrative
12 decision" is defined as in Section 3-101 of the Administrative
13 Review Law. Proceedings for judicial review shall be commenced
14 in the circuit court of the county in which the party applying
15 for review resides. If the party is not a resident of this
16 State, the venue shall be in Sangamon County.
 
17     Section 135. Certification of record. The Department shall
18 not be required to certify any record to the court or file any
19 answer in court or otherwise appear in any court in a judicial
20 review proceeding, unless there is filed in the court, with the
21 complaint, a receipt from the Department acknowledging payment
22 of the costs of furnishing and certifying the record, which
23 costs shall be computed at the actual cost per page of such
24 record. Failure on the part of the plaintiff to file such

 

 

HB1544 - 31 - LRB095 05319 RAS 25399 b

1 receipt in court shall be grounds for dismissal of the action.
 
2     Section 140. Criminal penalties. Any person who is found
3 to have violated any provision of the Act is guilty of a Class
4 A misdemeanor for the first offense, and a Class 4 felony for
5 second and subsequent offenses.
 
6     Section 145. Illinois Administrative Procedure Act. The
7 Illinois Administrative Procedure Act is hereby expressly
8 adopted and incorporated herein as if all of the provisions of
9 such Act were included in this Act, except that the provision
10 of paragraph (d) of Section 10-65 of The Illinois
11 Administrative Procedure Act, which provides that at hearings
12 the licensee has the right to show compliance with all lawful
13 requirements for retention, continuation, or renewal of the
14 license is specifically excluded. For the purpose of this Act,
15 the notice required under Section 10-25 of The Illinois
16 Administrative Procedure Act is deemed sufficient when mailed
17 to the last know address of a party.
 
18     Section 150. Home rule. The regulation and licensing of
19 clinical laboratory practitioners are exclusive powers and
20 functions of the State. A unit of local government, including
21 home rule units, may not regulate or license clinical
22 laboratory practitioners. This Section is a denial and
23 limitation under subsection (h) of Section 6 of Article VII of

 

 

HB1544 - 32 - LRB095 05319 RAS 25399 b

1 the Illinois Constitution.
 
2     Section 997. Severability. The provisions of this Act are
3 severable under Section 1.31 of the Statute on Statutes.
 
4     Section 999. Effective date. This Act takes effect upon
5 becoming law.